On the ‘red list’ in Vietnam? Oct 28, 2014 Why are pharma companies in India still falling foul of overseas regulators?
Playing the frenemy card Oct 10, 2014 AIDAN’s PIL accusing the DoP of 'browbeating' the NPPA might not be so far-fetched as innovators and generic companies cosy up…
Beyond pricing and patents Sep 30, 2014 Emerging market strategies of Big Pharma have been defined by two Ps: pricing and patents
Rx for NaMo’s next 100 days and beyond Sep 18, 2014 Prime Minister Modi's first 100 days in office may not have quite met the expectations of India Pharma Inc but the cautious…
Adding bite to DCG(I)’s bark Sep 1, 2014 On August 6, the quality assurance (QA) division of the CDSCO had released guidelines on the procedures to be followed by its…
The Ebola effect Aug 18, 2014 The fear of the Ebola Virus Disease (EVD) being imported into India is worrying our Parliamentarians but besides relying on…
India’s loss, China’s gain? Jul 31, 2014 India's drug pricing authority, the National Pharmaceutical Pricing Authority is once again at loggerheads with the industry
Budget 2014: Will implementation live up to intent? Jul 17, 2014 I had ended my last edit with the hope that this year, unlike previous years, the pharmaceutical sector’s hopes would not be as…
Wish upon on a star Jul 2, 2014 Narendra Modi's massive electoral mandate has unfortunately raised expectations; both from the man on the street as well as from…
No easy wins in pharma Jun 6, 2014 As we go to press, the Pfizer-AstraZeneca deal is called off for now but that story is far from over
More to rules than the carrot-and-stick approach May 15, 2014 Above revenues and reputation, is patient health and safety. If that's compromised, everything is lost
US, India face off on IP yet again May 8, 2014 As we await the US Trade Representative's annual Special 301 Report, stakeholders on both sides of the fence seem to be hardening…
Three more cos face US FDA ire-1 Apr 16, 2014 Last month, the US FDA has reportedly issued 483s to at least three more pharmaceutical companies in India, one of them the Indian…
Walking the talk on GCP Mar 26, 2014 “If we are interested in exporting medicines, we have to also import the standards.”
Bitter medicine Mar 18, 2014 Name-Shame-Blame-Train. This has been the pharmaceutical industry's mantra to manage non-compliance
Raising the bar Mar 3, 2014 After visiting the Taj Mahal on her recent visit to India, FDA Commissioner Margaret A Hamburg blogged, “those responsible for…
Recruiting right Feb 17, 2014 Blogging about her recent trip to India, Margaret Hamburg, Commissioner of the US Food and Drug Administration (FDA) spoke about…
Light at the end of the biotech tunnel? Jan 30, 2014 As we go to press with this special issue focussing on the biotechnology sector in India, Biocon's Q3 results seem like a light at…
In search of greener pastures Jan 17, 2014 After hanging fire for the past few months, the Department of Industrial Policy and Promotion (DIPP) has finally given some…